Alexander Birkmann, PhD

Head of Research
AiCuris Anti-Infective Cures AG, Germany

Alexander Birkmann holds a PhD in biology and has more than 20 years of experience in the pharmaceutical industry in various positions in drug research and development. As project leader, he was responsible for the development of pritelivir from preclinical stage through Phase 2 clinical trials. Since 2015 he is Head of Research at AiCuris.

Disclosure information not submitted.

Presentation(s):

• O5.5 - Pritelivir for the treatment of resistant HSV infections in immunocompromised patients: update on an ongoing Phase 3 trial and Early Access Program

  Tuesday, July 25, 2023
  15:30 – 15:45 CST